Ranked in 2 Practice Areas
3

Band 3

Healthcare (PRC Firms)

China

3 Years Ranked

4

Band 4

Corporate/M&A (PRC Firms)

China

3 Years Ranked

Ranked in Guides

About

Provided by Chengyao (Aaron) Zhou

Greater China Region

Practice Areas

Mergers and acquisitions, private equity investment, venture capital investment, healthcare-related (BD) transactions, outbound investment, foreign direct investment (FDI), joint ventures, restructuring, liquidation and general corporate matters

Career

Mr. Zhou has over 20 years’ legal experience, including eight years at Han Kun, five years at a leading Wal Street law firm, three years as the Asia Pacific legal head of a Fortune Global 50 company and legal counsel for the healthcare business of a Fortune Global 500 company.

Professional Memberships

Member of the PRC Bar; Member of the New York State Bar

Industry Sector Expertise

Pharmaceutical, medical device, technology, the Internet, telecommunications, new energy, natural resources, automobile, electric vehicles, healthcare management, insurance, finance, culture and entertainment

Languages Spoken

English, Mandarin Chinese, Cantonese

Experience

Mr. Zhou has represented many renowned companies and institutions in merger and acquisition transactions, private equity financing and venture capital investment projects. Mr. Zhou has also helped many multinational and PRC pharmaceutical, biotech and medical device companies in out-license/in-license for the commercialization, development and manufacturing of pharmaceutical products and medical devices, NewCo transactions, sale and purchase of healthcare-related assets and businesses, research collaboration, CRO, CSO and CMO agreements, supply agreements, distribution transactions, MTAs as well as regulatory, FCPA-related and compliance matters. He provides a full range of legal services in these transactions and projects, including deal structuring, legal due diligence, drafting and reviewing transaction documents, and leading negotiations. He has also helped PRC companies in their IPOs and listings on overseas stock exchanges, U.S. dollar and euro bond issuances, and listed company restructurings. Mr. Zhou is a member of the Equity Investment Committee and the Foreign Investment and Opening-up Committee of the Insurance Asset Management Association of China.

Publications

Pharmaceutical and Healthcare:

License-in – Let's Talk About "Money" First

License-in – What Else Matters Other Than "Money"

From the Legal Due Diligence Perspective – New Regulations Regarding the Registration and Manufacturing of Pharmaceutical Products

Key Issues in Pharmaceutical Asset Sale and Purchase Transactions

Supply Arrangement in Pharmaceutical-Related Transactions

In-depth Overview and Observations of Pharmaceutical Cooperation and Development Transactions

AI in Pharmaceutical R&D (Part I) – Market Observation and Collaboration Models

AI in Pharmaceutical R&D (Part II) – Key Terms of Collaboration Agreements

Strategies of "Material Transfer" – the Transitional Phase of Pharmaceutical-Related Transactions

Thoughtful Overview of "Upstream and Downstream" – Sublicensees' Rights and Interests in Pharmaceutical-Related License-in/License-out Transactions;

Outbound Investment & FDI:

The Final CFIUS Regulations and their Potential Impact on Chinese Overseas Investment

Decoupling in Action – The Potential Summary of the Impact of New Export Control Rules and the SEC's Public Statement and New Export Control Rules on Chinese and Non-Chinese Entities and Investors

China Provides a Sneak Peek into the Parameters of its Own CFIUS Regime – Analysis of the Foreign Investment Security Review Measures;

Photovoltaic:

Overview, Trend and Insight of Photovoltaic Industry

Common Transaction Structures for Acquisitions of Equity Interest in Photovoltaic Power Stations

Common Risks and Preventive Measures in Acquisition of Photovoltaic Power Stations;

Insurance:

Innovation for Eighteen Years – Things to Know About Rules on Insurance Asset Management Companies (Part I & Part II)

A New Era Announced – PE/VC Equity Investment of Insurance Funds;

Others:

Reform of Capital Contribution Rules in the 2023 Company Law – What Companies and Shareholders Need to Know

Education

East China University of Political Science & Law

LL.B.

1996 - 2000

University College London

LL.M.

2002 - 2003

the University of Chicago

LL.M.

2010 - 2011

Awards

Next Generation Partner in Corporate and M&A

Legal 500 Asia Pacific, 2020-2025

Next Generation Partner in Life Science & Healthcare

Legal 500 Asia Pacific, 2022-2025

Leading Lawyer in Corporate/M&A

Chambers Global, 2023-2024

Leading Lawyer in Corporate/M&A and Healthcare

Chambers Greater China Region, 2022-2024

Notable practitioner in Corporate and M&A, Restructuring and insolvency

IFLR1000, 2022-2024

Top 15 Rising Lawyers

ALB

2018

Chambers Review

Provided by Chambers

Greater China Region

Healthcare (PRC Firms) - China

3
Band 3
Individual Editorial

Zhou Chengyao has considerable expertise in healthcare transactions, assisting clients with cross-border licensing and financing matters. He typically advises entities in the pharmaceutical and biotechnology spaces, as well as private equity funds.

领先律师

周成曜律师在医疗保健交易方面拥有丰富的专业知识,协助客户处理跨境许可和融资事宜。他经常为制药和生物科技公司以及私募基金提供法律意见。


Corporate/M&A (PRC Firms) - China

4
Band 4
Individual Editorial

Aaron Zhou (Zhou Chengyao) has notable experience in handling cross-border and domestic M&A and investment restructuring. He is dual-qualified in Mainland China and New York State.

领先律师

周成曜律师在处理跨境和国内并购及投资重组方面具有丰富的经验。他拥有中国大陆和纽约州的双重执业资格。

Contributions

Latest contributions provided by Chengyao (Aaron) Zhou

Global Practice Guide
Aaron Zhou
Ray Shi
Daniel Xu
Liming Yuan
Authored by
Aaron Zhou, Ray Shi, Daniel Xu, Liming Yuan
Article • May 2024
Global Practice Guide
Aaron Zhou
Ray Shi
Daniel Xu
Liming Yuan
Authored by
Aaron Zhou, Ray Shi, Daniel Xu, Liming Yuan
Article • May 2024

Strengths

Provided by Chambers

Discover other Lawyers at
Han Kun Law Offices

Provided by Chambers
Filter by
Band

China

Aviation: Finance (PRC Firms)

Shu Wang
1
Shu Wang
1
Band 1
Jun Zhu
3
Jun Zhu
3
Band 3
Yi Ding
3
Yi Ding
3
Band 3
Xinfeng Zhang
4
Xinfeng Zhang
4
Band 4
Banking & Finance (PRC Firms)

Tiecheng Yang
2
Tiecheng Yang
2
Band 2
Yi Ding
4
Yi Ding
4
Band 4
Yuzhou Xu
5
Yuzhou Xu
5
Band 5
Capital Markets: Debt & Equity (PRC Firms)

Yijun Chao
E
Yijun Chao
E
Eminent Practitioners
Ping Xu
3
Ping Xu
3
Band 3
Bing Xue
4
Bing Xue
4
Band 4
Jin Wang
4
Jin Wang
4
Band 4
Capital Markets: High-Yield Products (International Firms)

3
Liang (Alex) Tao
3
Band 3
Capital Markets: Securitisation & Derivatives (PRC Firms)

Rong Fang
2
Rong Fang
2
Band 2
Competition/Antitrust (PRC Firms)

Chen Ma
2
Chen Ma
2
Band 2
Shipo (Angus) Xie
4
Shipo (Angus) Xie
4
Band 4
Da Shi
U
Da Shi
U
Up and Coming
Corporate Investigations/Anti-Corruption (PRC Firms)

Sophie Shi
U
Sophie Shi
U
Up and Coming
Jolie Yan
Jolie Yan
Associates to watch
Corporate Investigations/Anti-Corruption: Foreign Legal Consultants (PRC Firms)

Michelle Gon
1
Michelle Gon
1
Band 1
Corporate/Commercial: Guangdong: Non-contentious (PRC Firms)

Bing Xue
2
Bing Xue
2
Band 2
20 of 49 results

Key Sectors

Provided by Han Kun Law Offices

Health and Life Sciences

Technology, Media and Telecoms (TMT)

Energy and Utilities

Insurance

Resources and Mining